Outpatient intravenous therapy ban hitting drugmakers hard

Some of the country’s largest drugmakers focusing on infusion medications and antibiotics have been hit hard by the gradual banning, over the past two years, of intravenous (IV) drug infusion at major Chinese hospital outpatient departments.

Lees hier het hele artikel